RE: Open offer sell and buy back18 May 2024 17:16
No Eureka01, I'm not in deramping mode, I'm in the speaking the truth and speaking the facts mode. If you read my comments properly, I've stated that the future does look bright for the company, but it does not look bright for shareholders. Shareholders are about to be badly diluted and any investment you have will be worth nothing, that's if it already isn't. Imagine if this drops to 0.00300 as I predict if this Placing goes ahead? We might not see that price if we can get AIHL moving and good news from CYP 2C19 in July. But if it did, and the products do take off and sentiment increases, your realistically looking at a tenfold increase possibly more. But for arguments sake lets just say it's a tenfold increase, from.00300 that's still only 3p. For the SP to hit 20 or 30p, would require at least full AIHL reccomendation, and/or FDA clearance.
Tiger16 - The company wouldn't have to neccessarily delist and go bankrupt. They can always raise cash through financing. If the products are so great, the company should be able to attract institutional investors. They will also have the non-pre-emptive firm placing, which is not conditional upon shareholder approval. This firm placing will generate 0.17M which is not a lot but should tie them over for a few weeks while they seek out other forms of financing. Every Fundraise this company has had, they have promised that some of the funds will be used for FDA approval, and every year nothing, not even an update on what is happening with FDA. How many times are they going to spin this line on shareholders. At the end of the day, it's us they're going to run to for funds when the going gets tough, so they should show us more respect by following through with their promises. Each to their own, but I will most certainly be voting No to this proposal.